INTERACTION OF ELONGATION FACTOR 1-ALPHA WITH LEUCINE-RICH REPEAT KINASE 2 IMPAIRS KINASE ACTIVITY AND MICROTUBULE BUNDLING IN VITRO

被引:41
|
作者
Gillardon, F. [1 ]
机构
[1] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, D-88397 Biberach, Germany
关键词
Parkinson's disease; leucine-rich repeat kinase 2; elongation factor 1-alpha; GTPase; microtubules; dynamics; PARKINSONS-DISEASE; FACTOR; 1A; ROC DOMAIN; LRRK2; PROTEIN; GTPASE; LEUCINE-RICH-REPEAT-KINASE-2; TRANSLOCATION; CYTOSKELETON; DEGRADATION;
D O I
10.1016/j.neuroscience.2009.06.051
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Autosomal dominant mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of late-onset Parkinson's disease. However, the regulators/effectors contributing to the (patho-)physiological functions of LRRK2 remain poorly defined. Here we show that human LRRK2 co-purifies/co-immunoprecipitates with elongation factor 1-alpha (EF1A). Co-incubation of recombinant LRRK2 and EF1A significantly reduces the kinase activity of LRRK2, whereas its GTPase activity remains unchanged. In addition to its canonical role in mRNA translation, EF1A maintains stability of the microtubule cytoskeleton. In the present study, EF1A promotes microtubule assembly in an in vitro tubulin polymerization assay which is impaired by co-incubation with LRRK2 at sub-stoichiometric concentrations. These findings suggest that the interaction between LRRK2 and EF1A may reciprocally modulate their physiological function. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 50 条
  • [31] Leucine-rich repeat kinase 2 (LRRK2) impairs function of the retromer-associated WASH complex
    Venderova, K.
    Kaing, D.
    Eismati, R.
    Joseph, R.
    Radek, L.
    Yu-Ju, H.
    Emily, H.
    Ariel, T.
    Ryan, F.
    Derek, F.
    MOVEMENT DISORDERS, 2015, 30 : S412 - S412
  • [32] Erratum: Role and mechanism of action of leucine-rich repeat kinase 1 in bone
    Weirong Xing
    Helen Goodluck
    Canjun Zeng
    Subburaman Mohan
    Bone Research, 5
  • [33] Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease
    Elliott, David A.
    Kim, Woojin S.
    Gorissen, Sarsha
    Halliday, Glenda M.
    Kwok, John B. J.
    MOVEMENT DISORDERS, 2012, 27 (08) : 1004 - 1011
  • [34] Leucine-rich repeat kinase 2 binds to lipid rafts in synaptic terminals
    Kubo, S.-l.
    Hatano, T.
    Mizuno, Y.
    Hattori, N.
    MOVEMENT DISORDERS, 2007, 22 : S21 - S21
  • [35] Design, synthesis, and evaluation of a selective chemosensor for leucine-rich repeat kinase 2
    Szalewski, David A.
    Beck, Jon R.
    Stains, Cliff I.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (24) : 5648 - 5651
  • [36] Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
    Russo, Isabella
    Di Benedetto, Giulietta
    Kaganovich, Alice
    Ding, Jinhui
    Mercatelli, Daniela
    Morari, Michele
    Cookson, Mark R.
    Bubacco, Luigi
    Greggio, Elisa
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [37] STRESS INDUCED FACTOR 2, a Leucine-Rich Repeat Kinase Regulates Basal Plant Pathogen Defense
    Yuan, Ning
    Yuan, Shuangrong
    Li, Zhigang
    Zhou, Man
    Wu, Peipei
    Hu, Qian
    Mendu, Venugopal
    Wang, Liangjiang
    Luo, Hong
    PLANT PHYSIOLOGY, 2018, 176 (04) : 3062 - 3080
  • [38] Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
    Isabella Russo
    Giulietta Di Benedetto
    Alice Kaganovich
    Jinhui Ding
    Daniela Mercatelli
    Michele Morari
    Mark R. Cookson
    Luigi Bubacco
    Elisa Greggio
    Journal of Neuroinflammation, 15
  • [39] Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors
    Estrada, Anthony A.
    Sweeney, Zachary K.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (17) : 6733 - 6746
  • [40] Effect of leucine-rich repeat kinase 2 (LRRK2) on protein synthesis
    Kim, Hyejung
    Son, Ilhong
    Seol, Wongi
    ANIMAL CELLS AND SYSTEMS, 2018, 22 (01) : 15 - 21